Alzamend Neuro (ALZN) Retained Earnings (2020 - 2026)
Alzamend Neuro's Retained Earnings came in at -$70.33 million for fiscal Q1 2027 (quarter ended Jul 31, 2026), compared with -$61.24 million a year earlier.
Powered by 
Analysis
Alzamend Neuro (ALZN) Retained Earnings (2020 - 2026) Analysis & Trends
At the end of FY2026 (ended Apr 30, 2026), Alzamend Neuro's Retained Earnings was -$67.31 million.
- Going back by fiscal year, Retained Earnings was -$58.54 million in FY2025, -$54.02 million in FY2024, -$44.07 million in FY2023 and -$29.19 million in FY2022.
- The fiscal Q1 2027 figure represents the lowest quarterly Retained Earnings in data going back to fiscal Q4 2020.
- Business Quant data shows ALZN's Retained Earnings at -$67.31 million (Q4 2026), -$64.44 million (Q3 2026) and -$62.24 million (Q2 2026) in the three fiscal quarters before Q1 2027.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 171.67 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | -17.33 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 63.27 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 40.86 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 12.59 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -22.28 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 2.20 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 112.09 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 15.69 Bn |
| 10 | Alzamend Neuro | 8.35 Mn | 8.35 Mn | - | -70.33 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | -70.33 Mn |
| Apr 30, 2026 | -67.31 Mn |
| Jan 31, 2026 | -64.44 Mn |
| Oct 31, 2025 | -62.24 Mn |
| Jul 31, 2025 | -61.24 Mn |
| Apr 30, 2025 | -58.54 Mn |
| Jan 31, 2025 | -57.40 Mn |
| Oct 31, 2024 | -56.41 Mn |
| Jul 31, 2024 | -54.99 Mn |
| Apr 30, 2024 | -54.02 Mn |
| Jan 31, 2024 | -53.17 Mn |
| Oct 31, 2023 | -50.51 Mn |
| Jul 31, 2023 | -47.60 Mn |
| Apr 30, 2023 | -44.07 Mn |
| Jan 31, 2023 | -40.77 Mn |
| Oct 31, 2022 | -35.34 Mn |
| Jul 31, 2022 | -32.23 Mn |
| Apr 30, 2022 | -29.19 Mn |
| Jan 31, 2022 | -25.33 Mn |
| Oct 31, 2021 | -22.75 Mn |
API Access
Alzamend Neuro Retained Earnings API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=retained-earnings&ticker=ALZN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "retained-earnings", "ticker": "ALZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=retained-earnings&ticker=ALZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();